Skip to main content

Table 1 Predictors of Treatment among Patients with Hypertension, 2003 Guidelines

From: Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines

Variable

Crude Odds Ratio (95% CI)

Adjusted Odds Ratio (95% CI)†

Age

  

≤50

1.00

 

51–60

1.17 (0.70–1.96)

 

61–70

1.47 (0.91–2.37)

 

≥71

1.42 (0.88–2.28)

 

Gender

  

Male

1.00

 

Female

1.26 (0.97–1.63)

 

Diabetes

  

Type I

1.55 (0.75–3.18)

 

Type II

1.00

 

Treatment *

  

Diet

1.00

1.00

Oral meds

1.89 (1.31–2.74)

1.89 (1.31–2.74)

Insulin

1.04 (0.77–1.41)

1.04 (0.77–1.41)

Insulin + Oral

2.48 (1.13–5.43)

2.48 (1.13–5.43)

Kidney Disease **

  

None

1.00

 

Mild

1.32 (0.90–1.94)

 

Moderate

0.97 (0.65–1.45)

 

Severe

1.23 (0.34–4.50)

 

Failure

not valid

 

Years Since Diagnosis

  

≤5

1.00

 

6–10

0.86 (0.62–1.19)

 

≥11

1.32 (0.98–1.78)

 

Years Since Referral

  

≤3

1.00

 

4–7

0.84 (0.61–1.17)

 

≥8

0.94 (0.67–1.31)

 

Weight (KG)

  

≤55

1.00

 

56–67

0.78 (0.35–1.71)

 

68–90

0.87 (0.42–1.80)

 

≥91

0.99 (0.47–2.06)

 
  1. * Oral meds mean taking only oral antihyperglycemic medication; Insulin + Oral means patients who are taking insulin plus oral antihyperglycemic medication.
  2. ** Presence and stage of kidney disease as measured using the Cockroft-Gault formula.
  3. † Treatment was the only significant predictor, and therefore is not adjusted.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840